Features of Pure Progestin Contraception in Women with Pre-Eclampsia/Eclapmsis

Abstract preeclampsia (PE)/eclampsia (E) refers to emergency conditions in obstetrics. According to WHO data from a study of maternal and child health, including data from 29 countries (World Health Organization Multicountry Survey on Maternal and Newborn Health (WHOMCS), hypertensive conditions during pregnancy are conditions that are potentially life-threatening to a woman, increasing the risk of near-miss cases by 8 times in women with preeclampsia/eclampsia. Complications of pregnancy and the early postpartum period caused by preeclampsia/eclampsia have been studied and included in clinical guidelines regulating their diagnosis, prevention and treatment. However, preeclampsia/eclampsia is associated with long-term risks of complications that threaten not only health. but also the life of a woman over the next decades. Early preeclampsia and the presence of one birth increase the risk of cardiovascular death of a woman in later life. Not only pregnancy, but also the postpartum period pose a threat to a woman’s life. The risks of preeclampsia are 4.1% during the first pregnancy and 1.7% at subsequent pregnancy. However, the risk can reach 14.7% for a second pregnancy if the first pregnancy was complicated by preeclampsia, and 31.9% if the previous two pregnancies were complicated by preeclampsia. The risk of recurrence of preeclampsia increases as the interval to subsequent pregnancy lengthens. Key words: preeclampsia, intrauterine device contraception, eclampsia, pure progestin contraception.